特集 : 国別レポートが13,000件から検索可能になりました!

特集 : 海外市場の委託調査がセミカスタムベースでお手軽にできます

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

電気生理学装置:医療機器のパイプライン評価

Electrophysiology Devices - Medical Devices Pipeline Assessment, 2019

発行 GlobalData 商品コード 350912
出版日 ページ情報 英文 297 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.13円で換算しております。
電気生理学装置:医療機器のパイプライン評価 Electrophysiology Devices - Medical Devices Pipeline Assessment, 2019
出版日: 2019年12月24日 ページ情報: 英文 297 Pages
概要

当レポートでは、世界の電気生理学装置の市場における、主要なパイプライン製品 (医療機器) とその治験の進行状況について調査すると共に、製品特性の比較分析 (治験の進行段階別) や、主要企業のプロファイルおよび代表的製品、昨今の市場動静 (資本取引・事業提携など) といった情報を取りまとめてお届けいたします。

第1章 目次

第2章 イントロダクション

  • 電気生理学装置市場の概要

第3章 電気生理学装置市場:治験中の製品

  • パイプライン製品:治験段階別
  • パイプライン製品:セグメント別
  • パイプライン製品:地域別
  • パイプライン製品:規制経路別
  • パイプライン製品:推定認証時期別
  • パイプライン製品:現在進行中の治験

第4章 治験中のパイプライン製品:企業別

  • 電気生理学装置の企業:治験段階別のパイプライン製品
  • 電気生理学装置:治験段階別のパイプライン製品

第5章 電気生理学装置市場:企業・製品の概要

  • AblaCor Medical Corporation
    • パイプライン製品および進行中の治験の概要
  • Acutus Medical, Inc.
  • Advanced Cardiac Therapeutics, Inc.
  • AFfix Medical Ltd.
  • Apama Medical, Inc.
  • AtriCure, Inc.
  • Baylor College of Medicine
  • Biosense Webster, Inc.
  • BioSig Technologies, Inc.
  • BioTex, Inc.
  • Boston Scientific Corporation
  • C. R. Bard, Inc.
  • Cardima, Inc. (Inactive)
  • CardioFocus, Inc.
  • CardioNova Ltd.
  • CathEffects LLC
  • CathRx Ltd
  • Cordis Corporation
  • CoRepair, Inc
  • CyberHeart Incorporated
  • Epicardial Technologies Inc
  • FocusStart Orthosensors
  • Fundacion para la Investigacion Biomedica del Hospital Gregorio Maranon
  • Hansen Medical, Inc.
  • Imricor Medical Systems, Inc.
  • Interventional Imaging, Inc.
  • Iowa Approach Inc.
  • Maestro Heart SA
  • Mayo Clinic
  • MC10, Inc.
  • Medicalgorithmics S.A.
  • Medispec LTD
  • Medlumics S.L.
  • Medtronic plc
  • MedWaves Incorporated
  • MicroPort Scientific
  • MRI Interventions, Inc
  • nContact, Inc.
  • North Carolina State University
  • Northwestern University
  • Philips Healthcare
  • SCR, Inc.
  • St. Jude Medical, Inc.
  • Stereotaxis, Inc.
  • Strategic Polymer Sciences, Inc
  • The Cleveland Clinic Foundation
  • University of Rochester
  • University of Texas Medical Branch at Galveston
  • Vimecon GmbH
  • Vivonics, Inc.
  • Voyage Medical

第6章 電気生理学装置市場:昨今の動向

第7章 付録

図表一覧

図表

List of Tables

  • Table 1: Electrophysiology Devices - Pipeline Products by Stage of Development 18
  • Table 2: Electrophysiology Devices - Pipeline Products by Segment 19
  • Table 3: Electrophysiology Devices - Pipeline Products by Territory 20
  • Table 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 21
  • Table 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 22
  • Table 6: Electrophysiology Devices - Ongoing Clinical Trials 23
  • Table 7: Electrophysiology Devices Companies - Pipeline Products by Stage of Development 24
  • Table 8: Electrophysiology Devices - Pipeline Products by Stage of Development 27
  • Table 9: Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • Table 10: Ablasense - Product Status 31
  • Table 11: Ablasense - Product Description 31
  • Table 12: Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • Table 13: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Status 32
  • Table 14: LUMINIZE Radiofrequency (RF) Balloon Catheter - Product Description 32
  • Table 15: AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • Table 16: Next Generation RF Generator - Product Status 33
  • Table 17: Next Generation RF Generator - Product Description 33
  • Table 18: Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • Table 19: Endovascular Cardiac Optical Mapping Device - Product Status 34
  • Table 20: Endovascular Cardiac Optical Mapping Device - Product Description 34
  • Table 21: Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • Table 22: EPstar Diagnostic Fixed Electrophysiology Catheter - Product Status 35
  • Table 23: EPstar Diagnostic Fixed Electrophysiology Catheter - Product Description 36
  • Table 24: EPstar Diagnostic Fixed Electrophysiology Lumen Catheter - Product Status 36
  • Table 25: EPstar Diagnostic Fixed Electrophysiology Lumen Catheter - Product Description 37
  • Table 26: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 27: Catheter-Based Electrophysiological Imaging System - Product Status 38
  • Table 28: Catheter-Based Electrophysiological Imaging System - Product Description 38
  • Table 29: Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 39
  • Table 30: Excitation Wave Cancellation Device - Product Status 39
  • Table 31: Excitation Wave Cancellation Device - Product Description 39
  • Table 32: Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
  • Table 33: Berlin Heals Cardiac Microcurrent Therapy Device - Product Status 40
  • Table 34: Berlin Heals Cardiac Microcurrent Therapy Device - Product Description 40
  • Table 35: Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 36: CARTO 4 - Product Status 41
  • Table 37: CARTO 4 - Product Description 41
  • Table 38: CARTO SMARTTOUCH 5D Catheter - Product Status 42
  • Table 39: CARTO SMARTTOUCH 5D Catheter - Product Description 42
  • Table 40: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Status 42
  • Table 41: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter - Product Description 43
  • Table 42: Navigation Guided Deflectable Sheath - Product Status 43
  • Table 43: Navigation Guided Deflectable Sheath - Product Description 43
  • Table 44: THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Status 44
  • Table 45: THERMOCOOL SMARTTOUCH SF-5D Catheter - Product Description 44
  • Table 46: Biosense Webster Inc - Ongoing Clinical Trials Overview 45
  • Table 47: HELIOSTAR Multi-Electrode Radiofrequency Balloon Ablation Catheter - Safety and Effectiveness Evaluation of the Multi-electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation: STELLAR 46
  • Table 48: Navigation Guided Deflectable Sheath - Randomized Trial of Conventional Versus Radiofrequency Needle Transseptal Puncture for Cryoballoon Ablation 47
  • Table 49: THERMOCOOL SMARTTOUCH SF-5D Catheter - U.S. Investigational Device Exemption (IDE) Study to Evaluate QDOT MICRO Radiofrequency (RF) Ablation Catheter for Treatment of Paroxysmal Atrial Fibrillation (AF) 48
  • Table 50: BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 51: PURE EP System - Product Status 49
  • Table 52: PURE EP System - Product Description 49
  • Table 53: PURE EP Version 2.0 - Product Status 50
  • Table 54: PURE EP Version 2.0 - Product Description 50
  • Table 55: PURE EP Version 3.0 - Product Status 50
  • Table 56: PURE EP Version 3.0 - Product Description 51
  • Table 57: BioSig Technologies Inc - Ongoing Clinical Trials Overview 52
  • Table 58: PURE EP System - Validation of Safety and efficacy of the PURE EP System During Mapping and Ablation Procedures in Cardiac EP lab 53
  • Table 59: PURE EP Version 2.0 - Novel Cardiac Signal Processing System for Electrophysiology Procedures 54
  • Table 60: BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • Table 61: Cooled Tip Catheter - Product Status 55
  • Table 62: Cooled Tip Catheter - Product Description 55
  • Table 63: Water-cooled Catheter - Product Status 56
  • Table 64: Water-cooled Catheter - Product Description 56
  • Table 65: Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 66: Force Sensing Afib Catheter - Product Status 57
  • Table 67: Force Sensing Afib Catheter - Product Description 58
  • Table 68: Intellanav Stablepoint - Product Status 58

List of Figures

  • Figure 1: Electrophysiology Devices - Pipeline Products by Stage of Development 18
  • Figure 2: Electrophysiology Devices - Pipeline Products by Segment 19
  • Figure 3: Electrophysiology Devices - Pipeline Products by Territory 20
  • Figure 4: Electrophysiology Devices - Pipeline Products by Regulatory Path 21
  • Figure 5: Electrophysiology Devices - Pipeline Products by Estimated Approval Date 22
  • Figure 6: Electrophysiology Devices - Ongoing Clinical Trials 23
目次
Product Code: GDME0893EPD

GlobalData's Medical Devices sector report, "Electrophysiology Devices - Medical Devices Pipeline Assessment, 2019" provides an overview of Electrophysiology Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Electrophysiology Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Electrophysiology Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Electrophysiology Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Electrophysiology Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

  • 1.1 List of Tables 9
  • 1.2 List of Figures 15

2 Introduction 16

  • 2.1 Electrophysiology Devices Overview 16

3 Products under Development 18

  • 3.1 Electrophysiology Devices - Pipeline Products by Stage of Development 18
  • 3.2 Electrophysiology Devices - Pipeline Products by Segment 19
  • 3.3 Electrophysiology Devices - Pipeline Products by Territory 20
  • 3.4 Electrophysiology Devices - Pipeline Products by Regulatory Path 21
  • 3.5 Electrophysiology Devices - Pipeline Products by Estimated Approval Date 22
  • 3.6 Electrophysiology Devices - Ongoing Clinical Trials 23

4 Electrophysiology Devices - Pipeline Products under Development by Companies 24

  • 4.1 Electrophysiology Devices Companies - Pipeline Products by Stage of Development 24
  • 4.2 Electrophysiology Devices - Pipeline Products by Stage of Development 27

5 Electrophysiology Devices Companies and Product Overview 31

  • 5.1 Ablacon Inc Company Overview 31
    • 5.1.1 Ablacon Inc Pipeline Products & Ongoing Clinical Trials Overview 31
  • 5.2 Apama Medical Inc Company Overview 32
    • 5.2.1 Apama Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 32
  • 5.3 AtriCure Inc Company Overview 33
    • 5.3.1 AtriCure Inc Pipeline Products & Ongoing Clinical Trials Overview 33
  • 5.4 Aust Development, LLC Company Overview 34
    • 5.4.1 Aust Development, LLC Pipeline Products & Ongoing Clinical Trials Overview 34
  • 5.5 Baylis Medical Company Inc Company Overview 35
    • 5.5.1 Baylis Medical Company Inc Pipeline Products & Ongoing Clinical Trials Overview 35
  • 5.6 Baylor College of Medicine Company Overview 38
    • 5.6.1 Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview 38
  • 5.7 Ben-Gurion University of the Negev Company Overview 39
    • 5.7.1 Ben-Gurion University of the Negev Pipeline Products & Ongoing Clinical Trials Overview 39
  • 5.8 Berlin Heals GmbH Company Overview 40
    • 5.8.1 Berlin Heals GmbH Pipeline Products & Ongoing Clinical Trials Overview 40
  • 5.9 Biosense Webster Inc Company Overview 41
    • 5.9.1 Biosense Webster Inc Pipeline Products & Ongoing Clinical Trials Overview 41
  • 5.10 BioSig Technologies Inc Company Overview 49
    • 5.10.1 BioSig Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • 5.11 BioTex Inc Company Overview 55
    • 5.11.1 BioTex Inc Pipeline Products & Ongoing Clinical Trials Overview 55
  • 5.12 Boston Scientific Corp Company Overview 57
    • 5.12.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 57
  • 5.13 Cardima, Inc. (Inactive) Company Overview 67
    • 5.13.1 Cardima, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 67
  • 5.14 CardioNova Ltd Company Overview 69
    • 5.14.1 CardioNova Ltd Pipeline Products & Ongoing Clinical Trials Overview 69
  • 5.15 CathEffects LLC Company Overview 70
    • 5.15.1 CathEffects LLC Pipeline Products & Ongoing Clinical Trials Overview 70
  • 5.16 CathRx Ltd Company Overview 71
    • 5.16.1 CathRx Ltd Pipeline Products & Ongoing Clinical Trials Overview 71
  • 5.17 CathVision Aps Company Overview 78
    • 5.17.1 CathVision Aps Pipeline Products & Ongoing Clinical Trials Overview 78
  • 5.18 Cibiem Inc Company Overview 79
    • 5.18.1 Cibiem Inc Pipeline Products & Ongoing Clinical Trials Overview 79
  • 5.19 Columbia University Company Overview 82
    • 5.19.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview 82
  • 5.20 Cordis Corp Company Overview 83
    • 5.20.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 83

6 Electrophysiology Devices- Recent Developments 159

  • 6.1 Nov 22, 2019: Stereotaxis CEO to present at the 12th Annual BIOMEDevice San Jose Conference 159
  • 6.2 Nov 21, 2019: BioSig commences clinical trial enrollment for PURE EP System 159
  • 6.3 Nov 20, 2019: Former Cleveland Clinic CEO Toby Cosgrove, MD, joins InnovaHealth Partners as Senior Advisor 160
  • 6.4 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 160
  • 6.5 Nov 18, 2019: Freudenberg Medical launches wave of product and process innovations 163

7 Appendix 294

  • 7.1 Methodology 294
  • 7.2 About GlobalData 297
  • 7.3 Contact Us 297
  • 7.4 Disclaimer 297